<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://mail.scholarlyresources.digitalscholarship.brown.edu/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="https://mail.scholarlyresources.digitalscholarship.brown.edu/feed.php">
        <title>My wiki - observational_research_on_tianeptine_sodium_30</title>
        <description></description>
        <link>https://mail.scholarlyresources.digitalscholarship.brown.edu/</link>
        <image rdf:resource="https://mail.scholarlyresources.digitalscholarship.brown.edu/lib/exe/fetch.php?media=wiki:dokuwiki.svg" />
       <dc:date>2026-06-29T06:20:08+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="https://mail.scholarlyresources.digitalscholarship.brown.edu/doku.php?id=observational_research_on_tianeptine_sodium_30:efficacy_mechanisms&amp;rev=1770583511&amp;do=diff"/>
                <rdf:li rdf:resource="https://mail.scholarlyresources.digitalscholarship.brown.edu/doku.php?id=observational_research_on_tianeptine_sodium_30:efficacy_safety_and&amp;rev=1770583534&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="https://mail.scholarlyresources.digitalscholarship.brown.edu/lib/exe/fetch.php?media=wiki:dokuwiki.svg">
        <title>My wiki</title>
        <link>https://mail.scholarlyresources.digitalscholarship.brown.edu/</link>
        <url>https://mail.scholarlyresources.digitalscholarship.brown.edu/lib/exe/fetch.php?media=wiki:dokuwiki.svg</url>
    </image>
    <item rdf:about="https://mail.scholarlyresources.digitalscholarship.brown.edu/doku.php?id=observational_research_on_tianeptine_sodium_30:efficacy_mechanisms&amp;rev=1770583511&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-08T20:45:11+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>efficacy_mechanisms</title>
        <link>https://mail.scholarlyresources.digitalscholarship.brown.edu/doku.php?id=observational_research_on_tianeptine_sodium_30:efficacy_mechanisms&amp;rev=1770583511&amp;do=diff</link>
        <description>Tianeptine Sodium, a unique antidepressant, has garnered attention for its distinct pharmacological profile and therapeutic effects. Originally developed in the 1960s in France, Tianeptine is primarily used for the treatment of major depressive disorder (MDD) and has been noted for its anxiolytic properties. This observational research article aims to explore</description>
    </item>
    <item rdf:about="https://mail.scholarlyresources.digitalscholarship.brown.edu/doku.php?id=observational_research_on_tianeptine_sodium_30:efficacy_safety_and&amp;rev=1770583534&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-08T20:45:34+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>efficacy_safety_and</title>
        <link>https://mail.scholarlyresources.digitalscholarship.brown.edu/doku.php?id=observational_research_on_tianeptine_sodium_30:efficacy_safety_and&amp;rev=1770583534&amp;do=diff</link>
        <description>(Image: https://c19early.org/jzcav/holliday.png)
Tianeptine Sodium, a unique antidepressant, has garnered significant attention in recent years due to its distinct mechanism of action and therapeutic potential. Initially developed in France in the 1960s, Tianeptine has primarily been used for the treatment of major depressive disorder (MDD) and anxiety-related conditions. This observational research article aims to explore the efficacy, safety, and patient perspectives on Tianeptine Sodium 30, a…</description>
    </item>
</rdf:RDF>
